Literature DB >> 10194301

Site-directed mutagenesis of phosphate-contacting amino acids of bovine pancreatic deoxyribonuclease I.

S J Evans1, E J Shipstone, W N Maughan, B A Connolly.   

Abstract

Bovine pancreatic deoxyribonuclease I (DNase I) is an endonuclease which cleaves double-stranded DNA. Cocrystal structures of DNase I with oligonucleotides have revealed interactions between the side chains of several amino acids (N74, R111, N170, S206, T207, and Y211) and the DNA phosphates. The effects these interactions have on enzyme catalysis and DNA hydrolysis selectivity have been investigated by site-directed mutagenesis. Mutations to R111, N170, T207, and Y211 severely compromised activity toward both DNA and a small chromophoric substrate. A hydrogen bond between R111 (which interacts with the phosphate immediately 5' to the cutting site) and the essential amino acid H134 is probably required to maintain this histidine in the correct orientation for efficient hydrolysis. Both T207 and Y211 bind to the phosphate immediately 3' to the cleavage site. Additionally, T207 is involved in binding an essential, structural, calcium ion, and Y211 is the nearest neighbor to D212, a critical catalytic residue. N170 interacts with the scissile phosphate and appears to play a direct role in the catalytic mechanism. The mutation N74D, which interacts with a phosphate twice removed from the scissile group, strongly reduced DNA hydrolysis. However, a comparison of DNase I variants from several species suggests that certain amino acids, which allow interaction with phosphates (positively charged or hydrogen bonding), are tolerated. S206, which binds to a DNA phosphate two positions away from the cleavage site, appears to play a relatively unimportant role. None of the enzyme variants, including a triple mutation in which N74, R111, and Y211 were altered, affected DNA hydrolysis selectivity. This suggests that phosphate binding residues play no role in the selection of DNA substrates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194301     DOI: 10.1021/bi9824893

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Biological functions of the disulfides in bovine pancreatic deoxyribonuclease.

Authors:  Wei-Jung Chen; I-Shuan Lee; Ching-Ying Chen; Ta-Hsiu Liao
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

2.  CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity.

Authors:  M Lara-Tejero; J E Galán
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  A kinetic analysis of substrate recognition by uracil-DNA glycosylase from herpes simplex virus type 1.

Authors:  S R Bellamy; G S Baldwin
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

4.  Ca2+-dependent activity of human DNase I and its hyperactive variants.

Authors:  C Q Pan; R A Lazarus
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

5.  Physical and biochemical properties of mammalian DNase X proteins: non-AUG translation initiation of porcine and bovine mRNAs for DNase X.

Authors:  Daisuke Shiokawa; Yukari Shika; Kazuki Saito; Kosuke Yamazaki; Sei-ichi Tanuma
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

6.  Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway.

Authors:  Erik Haghjoo; Jorge E Galán
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

7.  How cations can assist DNase I in DNA binding and hydrolysis.

Authors:  Marc Guéroult; Daniel Picot; Joséphine Abi-Ghanem; Brigitte Hartmann; Marc Baaden
Journal:  PLoS Comput Biol       Date:  2010-11-18       Impact factor: 4.475

8.  Assessment of the optimization of affinity and specificity at protein-DNA interfaces.

Authors:  Justin Ashworth; David Baker
Journal:  Nucleic Acids Res       Date:  2009-04-23       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.